欧洲输血诊断市场预测至 2028 年 – COVID-19 影响和区域分析 – 按产品（仪器、试剂盒和试剂）、应用（血型和疾病筛查）和最终用户（医院、诊断实验室、血液）银行和血浆分馏公司）
No. of Pages: 140 | Report Code: BMIRE00027398 | Category: Life Sciences
No. of Pages: 140 | Report Code: BMIRE00027398 | Category: Life Sciences
慢性病患病率快速上升推动市场增长
世界各地的人们正在经历许多生活方式的改变，导致慢性疾病的患病率稳步上升。持续的城市化正在推动人们走向久坐的生活方式。各种住宅、商业和工业设施的现代化导致人们的体力活动减少，同时他们不断承受着个人、职业和社会因素造成的压力。输血是治疗贫血、癌症（某些类型）、地中海贫血、血友病和镰状细胞病等慢性疾病的一部分。慢性病负担日益加重影响着公共卫生、社会和经济。输血诊断广泛应用于各种外科手术，包括心脏手术和其他侵入性手术。慢性疾病，如癌症、心血管疾病和肾脏疾病，通常通过外科手术治疗，这可能会导致失血过多。因此，新鲜血液被注入患者体内以维持其血液水平。输血诊断溶液用于输血或回输过程中。因此，随着慢性病患病率的迅速上升，欧洲的输血诊断市场也在不断增长。
市场概况
欧洲输血诊断市场收入和预测到 2028 年（百万美元）
欧洲血液输血诊断市场细分
欧洲输血诊断市场根据产品、应用、最终用户和国家进行细分。< /p>
雅培； BAG 诊断有限公司； Bio-Rad 实验室公司； DiaSorin SpA； F.霍夫曼-拉罗氏有限公司；南澳州格里福斯； Immucor 有限公司； Ortho 临床诊断（QuidelOrtho 公司）；商数有限；和 Thermo Fisher Scientific Inc. 是欧洲输血诊断市场的领先公司。
Strategic insights for Europe Blood Transfusion Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 1,272.35 Million |
| Market Size by 2028 | US$ 1,858.70 Million |
| Global CAGR (2022 - 2028) | 6.5% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 产品
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Blood Transfusion Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Blood Transfusion Diagnostics Market is valued at US$ 1,272.35 Million in 2022, it is projected to reach US$ 1,858.70 Million by 2028.
As per our report Europe Blood Transfusion Diagnostics Market, the market size is valued at US$ 1,272.35 Million in 2022, projecting it to reach US$ 1,858.70 Million by 2028. This translates to a CAGR of approximately 6.5% during the forecast period.
The Europe Blood Transfusion Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Blood Transfusion Diagnostics Market report:
The Europe Blood Transfusion Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Blood Transfusion Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Blood Transfusion Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Blood Transfusion Diagnostics Market
